Clinical Trials
Our clinic trial news comes directly from the U.S. National Institutes of Health. If you have additional trial information please post it to our website or let us know by email.
CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: CC100; Drug: Placebos
Sponsor: Chemigen, LLC
Recruiting - verified February 2017
Interventions: Drug: CC100; Drug: Placebos
Sponsor: Chemigen, LLC
Recruiting - verified February 2017
Metabolic and Structural Characterization of Hub's Vulnerability in Neurological Diseases Assessed by Ultra High Field Structural and Functional MRI
Condition: Diffuse Diseases
Interventions: Device: MRI 7T; Device: MRI 3 T; Biological: blood sample
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified January 2017
Interventions: Device: MRI 7T; Device: MRI 3 T; Biological: blood sample
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified January 2017
MIROCALS: Modifying Immune Response and OutComes in ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Riluzole; Drug: IL-2; Drug: 5% glucose water solution
Sponsor: Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2017
Interventions: Drug: Riluzole; Drug: IL-2; Drug: 5% glucose water solution
Sponsor: Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2017
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
Conditions: Systemic Inflammation; Cardiopulmonary-bypass
Interventions: Drug: bRESCAP; Drug: placebo
Sponsors: Alloksys Life Sciences B.V.; Aix Scientifics; Singapore Clinical Research Institute
Not yet recruiting - verified February 2017
Interventions: Drug: bRESCAP; Drug: placebo
Sponsors: Alloksys Life Sciences B.V.; Aix Scientifics; Singapore Clinical Research Institute
Not yet recruiting - verified February 2017
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers
Conditions: Hepatitis B; Chronic Hepatitis B; Viral Hepatitis B
Interventions: Drug: AL-3778; Drug: Entecavir; Drug: Tenofovir disoproxil fumarate
Sponsor: Alios Biopharma Inc.
Recruiting - verified January 2017
Interventions: Drug: AL-3778; Drug: Entecavir; Drug: Tenofovir disoproxil fumarate
Sponsor: Alios Biopharma Inc.
Recruiting - verified January 2017
NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: NeuRx DPS
Sponsor: Synapse Biomedical
Not yet recruiting - verified January 2017
Intervention: Device: NeuRx DPS
Sponsor: Synapse Biomedical
Not yet recruiting - verified January 2017
Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)
Condition: ALS
Interventions: Drug: Perampanel; Drug: placebo
Sponsor: Tokyo Medical University
Not yet recruiting - verified January 2017
Interventions: Drug: Perampanel; Drug: placebo
Sponsor: Tokyo Medical University
Not yet recruiting - verified January 2017
Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients
Conditions: Kidney Transplant Rejection; Kidney Transplant; Complications
Interventions: Drug: Basiliximab; Drug: Thymoglobulin
Sponsor: Coordinación de Investigación en Salud, Mexico
Recruiting - verified December 2016
Interventions: Drug: Basiliximab; Drug: Thymoglobulin
Sponsor: Coordinación de Investigación en Salud, Mexico
Recruiting - verified December 2016
ALS Testing Through Home-based Outcome Measures
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: Respirometer, Handgrip Meter, Skulpt Chisel, ActigraphyMeter
Sponsors: Jeremy Shefner; Beth Israel Deaconess Medical Center
Not yet recruiting - verified January 2017
Intervention: Other: Respirometer, Handgrip Meter, Skulpt Chisel, ActigraphyMeter
Sponsors: Jeremy Shefner; Beth Israel Deaconess Medical Center
Not yet recruiting - verified January 2017